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This study was designed to determine the molecular charac-
teristics and antimicrobial resistance of enterococcal strains 
isolated from patients admitted to an Iranian Hospital. Entero-
coccal strains were isolated from the burn patients. All strains 
were screened for genes encoding resistance to aminoglycoside 
[aac(6’)-Ie-aph(2’’)-Ia, aph (3’), ant (4’)], resistance to vancomy-
cin (vanA, vanB), resistance to tetracycline (tetK, tetL, tetM, tetO), 
and resistance to erythromycin (ermA, ermB, ermC) by PCR and 
multiplex PCR-based methods. Genetic diversity was evaluated 
via Random Amplified Polymorphic DNA (RAPD)-PCR. All ente-
rococcal isolates showed complete sensitivity to vancomycin with 
MIC ≤ 0.5µg/ml. Resistance to gentamicin, tetracycline, erythro-
mycin, ciprofloxacin or quinopristin-dalfopristin was detected, 
whilst more than 96.2% of isolates were high-level gentamicin-
resistant (HLGR) and multiple drug resistant. The most prevalent 
aminoglycoside resistance gene was aac(6’)-Ie-aph(2’’)-Ia, that 
was found in 96.2% (26/27) of the isolates. The most prevalent 
tetracycline resistance genes were tetM, found in 85.1% (23/27) 
followed by tetL and tetO found in 7.4% (2/27) of the isolates. The 
ermA and ermB genes were detected in 33.3% (9/27) and 44.4% 
(12/27) of the isolates respectively. RAPD-PCR analysis yielded 
17 distinct profiles among 27 investigated isolates. One cluster 
of isolates shared the same RAPD pattern, while 16 isolates had 
unique RAPD pattern. Our study showed that during the examina-
tion time period one RAPD genotype was the common type and 
was disseminated among patients in the burn unit. Interestingly, 
most of these strains had an identical or very similar antibiotic 
and gene resistance pattern.
Original article
Prevalence of high-level gentamicin-resistant 
Enterococcus faecalis and Enterococcus faecium  
in an Iranian hospital
M. EMANEINI1 2, B. KHORAMIAN3, F. JABALAMELI2, R. BEIGVERDI2, K. ASADOLLAHI4, M. TAHERIKALANI5, A.R. LARI1
1 Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran; 2 Department of Microbiology, School 
of Medicine, Tehran University of Medical Sciences, Tehran, Iran; 3 Department of Clinical Sciences, Faculty of Veterinary Medicine, 
Ferdowsi University of Mashhad. Mashhad, Iran; 4 Department of Social Medicine, Faculty of Medicine, Ilam University of Medical 
Sciences, Ilam, Iran; 5 Razi Herbal Medicines Researches Center, Department of Microbiology, School of Medicine, Lorestan University 
of Medical Sciences, Khoramabad, Iran
Keywords
Enterococcus • HLGR • RAPD-PCR
Summary
Introduction
Enterococci are Gram-positive, facultative anaerobic bac-
teria that are members of the normal flora in the human 
gastrointestinal tract but have been recognized as important 
pathogens worldwide [1, 2]. Enterococcus faecalis and En-
terococcus faecium are the most prevalent species isolated 
from the urinary tract and wound infections, which affect 
mainly patients admitted to the medical care centers [3-6]. 
The disruption of the normal skin barrier, the immunocom-
promised state, prolonged hospitalization and antibiotic 
therapy put burns patients at a high risk of acquiring no-
socomial infections including enterococcal infections [7].
Enterococcal infections can be difficult to treat because 
they have a remarkable ability of adaptation when are ex-
posed to antibiotics; they have intrinsic resistance to sev-
eral antimicrobial agents and have a tremendous capacity 
to acquire high levels of resistance to antibiotics  [8, 9]. 
Vancomycin-resistant enterococci (VRE) and high-level 
gentamicin-resistant (HLGR) isolates have emerged as 
important pathogen in Iran as well as in other countries, 
which create serious challenges for treating the infected 
patients [9-11]. 
There are several reports on the endemicity of VRE and 
HLRG in Iran but there is a lack of information on ente-
rococcal stains isolated form burn centers [3, 12]. This 
study was designed to determine the molecular char-
acteristics and antimicrobial resistance of enterococcal 
strains isolated from patients in a burn center in Iran.
Materials and methods
Bacterial isolates
Twenty-seven enterococcal isolates were collected from 
wound specimens of patients with burn injury, during April 
to September 2012, in a burn hospital in Tehran. Only one 
isolate per patient was included in the study. Identification 
of enterococci was performed based on a series of conven-
tional microbiological tests including Gram reaction, cata-
lase reaction, presence of pyrrolidonyl arylamidase (PYR), 
growth on bile-aesculin agar and 6.5% NaCl media, motil-
ity test, arginine decarboxylation in Moeller decarboxylase 
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media, pyruvate utilization, and fermentation of arabinose, 
raffinose, mannitol and ribose [3]. To confirm the identity 
of the isolates as E. faecalis or E. faecium the ddlE gene was 
amplified by a polymerase chain reaction (PCR) method as 
described by Dutka-Malen et al. [13].
Antimicrobial susceptibility testing
Antibiotic susceptibility of the strains was performed by 
the disk diffusion method. The antibiotics (Mast Group 
Ltd., Merseyside, UK) tested were ciprofloxacin (5  µg), 
erythromycin (15 µg), tetracycline (30 µg), and quinupris-
tin-dalfopristin (15 µg). High-level resistance to gentamicin 
was also determined by disk diffusion method on Muel-
ler–Hinton agar (Conda S.A., Madrid, Spain) using 120 µg 
gentamicin disk. The minimal inhibitory concentration 
(MIC) of vancomycin was determined by the standard agar 
dilution test on Brain Heart Infusion agar (Conda S.A., Ma-
drid, Spain). All Antibiotic susceptibilities were performed 
and interpreted according to the criteria of the Clinical and 
Laboratory Standards Institute (CLSI) guidelines [14].
DNA extraction and gene detection
DNA extraction was performed as described previously 
and this DNA was used as a template for PCR analy-
sis [11]. All strains were screened for genes encoding re-
sistance to aminoglycoside [aac(6’)-Ie-aph(2’’)-Ia, aph 
(3’), ant (4’)], vancomycin (vanA, vanB), tetracycline 
(tetK, tetL, tetM, tetO), and resistance to erythromycin 
(ermA, ermB, ermC) by PCR and multiplex PCR-based 
methods, using specific primers [3, 11,12, 15, 16].
Random Amplified Polymorphic DNA  
(RAPD)-PCR
The RAPD-PCR assay was carried out in 25  µl re-
action volumes containing 0.5  µM of each primer 
(5´-AGCGGGCCAA-3´ and 5´- ACGGCCGACC-3´), 
12.5  µl of PCR master (Sinaclone Inc, Iran) and 5  µl 
of DNA template. Cycling conditions were as follow: 
initial denaturation at 95°C for 5 min, followed by 30 
cycles of 95°C for 1 min, 38.5°C for 1 min, and 72°C 
for 2 min, and final extension at 72°C for 10 min. PCR 
products were then separated by electrophoresis in 1.4% 
agarose gel with 0.5X TBE buffer. DNA bands were ob-
served by staining with KBC power load dye (Kawsar 
Biotech Co. Iran) and photographed under UV illumina-
tion. RAPD patterns were analyzed by visual inspection. 
Only the obvious, prominent and reproducible bands 
from repeated experiments (at least twice) were consid-
ered and any pattern differing by one or more bands was 
classified as a distinct RAPD type.
Results
Distribution of species according to conventional micro-
biological tests and PCR method included 19 (70.3%) E. 
faecalis and 8 (29.7%) E. faecium. The prevalence of an-
timicrobial resistance pattern and RAPD types have been 
summarized in Table I. In the present study, no VRE was 
recovered and all enterococcal isolates showed complete 
sensitivity to vancomycin with MIC ≤ 0.5 µg/ml. 
All isolates at least exhibited resistance to one antibi-
otic and 6 different profiles were observed on the basis 
of their antibiotic resistance patterns. High-level resist-
ance to gentamicin and multiple drug resistance were 
observed in 96.2% of isolates. The most frequent pro-
file was resistance to erythromycin, gentamicin, tetra-
cycline, quinupristin-dalfopristin and ciprofloxacin that 
was observed in 74% of isolates.
The most prevalent aminoglycoside resistance gene was 
aac(6’)-Ie-aph(2’’)-Ia, found in 96.2% (26/27) of the iso-
lates. These genes were detected in all HLGR isolates. 
The ant (4’) gene was detected in 62.9% (17/27) of iso-
lates. The most prevalent tetracycline resistance gene was 
tetM, found in 85.1% (23/27) of the isolates followed by 
tetL and tetO found in 7.4% (2/27) of the isolates. The 
ermA and ermB genes were detected in 33.3% (9/27) and 
44.4% (12/27) of the isolates respectively. The aph (3’), 
tetK, ermC, vanA, and vanB genes were not detected in 
any of the enterococcal isolates in this study.
To determine the degree of clonality among enterococ-
cal isolates, the RAPD typing was used. RAPD analysis 
yielded 17 distinct profiles among 27 investigated iso-
lates (Fig. 1). One clusters of isolates shared the same 
RAPD patterns, while 16 isolates had unique RAPD pat-
terns. A dominant RAPD type designated as A, that con-
sisted 11 isolates of E. faecalis and were HLGR.
Discussion
Among Enterococci isolates, E. faecalis and E. faecium are 
the most common species caused enterococcal nosocomial 
infections [1]. In our study, the most prevalent species was 
E. faecalis (70.3%) followed by E. faecium (29.7%) isolated 
from burn wound infections. Similar results were reported 
for clinical isolates by other studies [3, 11, 16, 17].
In the treatment of enterococcal infections, the combination 
of gentamicin with a beta lactam antibiotic or a glycopeptide 
is used to obtain a synergistic bactericidal effect. However, 
strains that are highly resistant to gentamicin are no longer 
susceptible to the combination therapy [18]. Several studies 
have demonstrated that VRE have caused both outbreaks 
and endemic infections in burn units [5, 6], However, in this 
study, there were no VRE isolates and more than 96% of 
isolates were HLGR and 74% of them were simultaneously 
resistant to erythromycin, tetracycline, quinupristin-dalfo-
pristin and ciprofloxacin. Our study is the first investigation 
on enterococcal resistance among burn patients in Iran and 
the findings indicated that vancomycin keeps its therapeutic 
effects against enterococcal infections. 
Resistance against aminoglycosides among enterococci is 
commonly due to enzymatic modification. Genes encoding 
aminoglycoside-modifying enzymes (AMEs) are often car-
ried on transposable elements. One of the most prevalent 
AMEs genes among enterococci is aac(6’)-Ie-aph(2’’)-Ia 
encoding a bifunctional enzyme Aac(6’)-Ie-Aph(2’’)-Ia 
which confers resistance to virtually all of the clinically 
available aminoglycosides including gentamicin [11, 19]. 
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In the current study, as in many other reports, the aac(6’)-
Ie-aph(2’’)-Ia gene was the most prevalent AME gene, 
encountered in 96.2% of isolates followed by the ant (4’) 
gene and was detected in 62.9% of isolates [16, 20]. 
Acquired resistance to tetracyclines and macrolides in ente-
rococci is often by mobile genetic elements [20]. In the pre-
sent study, as in many previous reports, the most common 
tetracycline and erythromycin resistance mechanism was 
mediated by the tetM and ermB genes, respectively [21-25]. 
To take preventive measures and apply infection con-
trol, identification of the source of infection and nature 
of outbreaks are required. RAPD-PCR has become a 
reliable tool for the differentiation and identification of 
enterococci from clinical origin [26-28]. In this study, 
RAPD-PCR profiles showed that eleven E. faecalis iso-
lates shared identical banding patterns. In addition, the 
results of RAPD typing corresponded with antibiogram 
findings and the resistance genes patterns for eight of 
these eleven isolates. This could be explained by the pre-
dominance or an outbreak of a particular clonal group of 
E. faecalis with high-level gentamicin resistance in the 
assessed burn unit.
In conclusion, we found that over the examination time 
period one RAPD genotype was the common type and 
was disseminated among patients in the burn unit. Inter-
estingly, most of these strains had an identical or very 
similar antibiotic and gene resistance pattern.
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Tab. I. The distribution of antimicrobial resistance genes, virulence genes and biofilm production among enterococcal species.
Isolate Date of Isolation Species Resistance pattern Resistance genes RAPD type
1 20/4/2012 E. faecalis E*,GM, TET,SYN,CIP tetM,ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
2 22/4/2012 E. faecium GM, TET, SYN tetM, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) B
3 24/4/2012 E. faecium E,GM, TET,SYN,CIP tetM, aac(6’)-Ie-aph(2’’)-Ia H
4 26/4/2012 E. faecium E,GM, TET tetL, tetM, ermB, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) G
5 26/4/2012 E. faecalis E,GM, TET tetM,ermB, aac(6’)-Ie-aph(2’’)-Ia P
6 1/5/2012 E. faecalis E,GM, TET,SYN,CIP tetM, ermB, aac(6’)-Ie-aph(2’’)-Ia A
7 4/5/2012 E. faecium E,GM, TET tetL, tetM, ermB, aac(6’)-Ie-aph(2’’)- Ia, ant(4’) J
8 8/5/2012 E. faecalis E,GM, TET,SYN,CIP ermB, aac(6’)-Ie-aph(2’’)-Ia A
9 15/5/2012 E. faecalis E,GM, TET,SYN,CIP tetM, aac(6’)-Ie-aph(2’’)-Ia N
10 2/6/2012 E. faecalis E,GM, TET,SYN,CIP tetM,ermB, aac(6’)-Ie-aph(2’’)-Ia A
11 12/7/2012 E. faecalis E,GM, TET,SYN,CIP tetM,ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
12 14/7/2012 E. faecalis E,GM, TET,SYN,CIP tetM,ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
13 14/7/2012 E. faecalis E,GM, TET,SYN,CIP tetM, ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
14 21/7/2012 E. faecalis E,GM, TET,SYN,CIP tetM, ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
15 23/7/2012 E. faecium TET tetM M
16 25/7/2012 E. faecium E,GM, TET,SYN,CIP tetM,ermB, aac(6’)-Ie-aph(2’’)-Ia F
17 7/8/2012 E. faecalis E,GM, TET,SYN,CIP tetM, ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
18 7/8/2012 E. faecalis GM,SYN,CIP tetM,ermB, aac(6’)-Ie-aph(2’’)-Ia E
19 14/8/2012 E. faecalis E,GM, TET,SYN,CIP ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) D
20 14/8/2012 E. faecalis E,GM, TET,SYN,CIP tetM,ermB, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) I
21 21/8/2012 E. faecalis E,GM, TET,SYN,CIP tetM,ermA, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
22 25/8/2012 E. faecalis E,GM, TET,SYN,CIP tetM,ermA aac(6’)-Ie-aph(2’’)-Ia, ant(4’) A
23 11/9/2012 E. faecalis E,GM, TET,SYN,CIP tetM,tetO, ermB, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) K
24 11/9/2012 E. faecium E, GM aac(6’)-Ie-aph(2’’)-Ia, ant(4’) Q
25 16/9/2012 E. faecalis E, GM,TET,SYN,CIP tetM, ermB, aac(6’)-Ie-aph(2’’)-Ia C
26 16/9/2012 E. faecalis E, GM,TET,SYN,CIP tetM aac(6’)-Ie-aph(2’’)-Ia, ant(4’) L
27 16/9/2012 E. faecium E, GM,TET,SYN,CIP tetM,tetO, ermB, aac(6’)-Ie-aph(2’’)-Ia, ant(4’) O
* E, Erythromycin; G, Gentamicin; SYN, Quinupristin-dalfopristin; TET, Tetracycline; CIP, Ciprofloxacin
Fig. 1. RAPD-PCR profiles of Enterococcus faecalis and E. faecium 
isolates. Lanes 1and 2; DNA size marker (100bp), Lanes A-Q; Ente-
rococcal isolates with different RAPD patterns.
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